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ABSTRACT
Objectives: To compare the free radical scavenging activity and antioxidant potentials of balofloxacin versus prulifloxacin.
Methods: Nitric oxide (NO) radical scavenging activity was determined using the method of Garret (1964). Sodium nitroprusside in aqueous solution 
at physiological pH spontaneously generates NO, which interacts with oxygen to produce nitrite ions which can be determined by the use of Griess 
ilosvay reaction. 2 mm of 10 mm sodium nitroprusside in 0.5 ml phosphate buffer saline (pH 7.4) was mixed with 0.5 ml prulifloxacin and balofloxacin 
at various concentrations and the mixture incubated at 25°C for 150 minutes. From the incubated mixture 0.5 ml was taken out and added into 1.0 ml 
sulfanilic acid reagent (30 in 20% glacial acetic acid) and incubated at room temperature for 5 minutes. Finally, 1.0 ml naphthylethylenediamine 
dihydrochloride (0.1% w/v) was mixed and incubated at room temperature for 30 minutes. The resultant absorbance was recorded at 540 nm using 





Results: At concentration of 10, 20, 30, and 40 µg/ml percentage inhibition observed with prulifloxacin and balofloxacin was 40.94, 53.09, 66.25, 
88.06 and 34.49, 49.09, 60.42, and 73.14, respectively. 
Conclusion: Thus, this in vitro study suggests that both prulifloxacin and balofloxacin possess antioxidant properties. At the lower doses both the 
drugs show similar antioxidant profile, while at the higher doses the antioxidant potential of prulifloxacin is significantly high than balofloxacin. 
However, the preference of selecting one over the other depends on the indication as well as the risk-benefit ratio.
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INTRODUCTION
Oxidative stress is suspected to be an important etiological factor 
in the pathogenesis of various diseases such as Parkinson’s disease, 
Alzheimer’s disease, Huntington’s disease, depression, and multiple 
sclerosis. Oxidative stress is also linked to certain cardiovascular 
disease since oxidation of the low-density lipoprotein in the vascular 
endothelium is a precursor to plaque formation. Oxidative stress is 
likely to be involved in age-related development of cancer. The reactive 
species produced in oxidative stress can cause direct damage to the 
DNA and are therefore mutagenic, and it may also suppress apoptosis 
and promote proliferation, invasiveness, and metastasis.
Although, reactive oxygen species (ROS) and reactive nitrogen 
species play an important roles in many biological processes and are 
involved in host defense, overproduction of these species such as 
hydroxyl radical (.OH), hydrogen peroxide (H2O2), superoxide anions 
(O2.−), and nitric oxide (NO.), as well as peroxyl nitrite contributes 
to the immunopathology of a vast variety of conditions including 
inflammatory diseases, cancer, atherosclerosis, diabetes mellitus, 
hypertension, AIDS, and aging (Darley-Usmar et al., 1995; Lee et al., 
2000) and also contribute to food deterioration [1].
An antioxidant is a molecule stable enough to donate an electron to a 
rampaging free radical and neutralize it, thus reducing its capacity to 
damage. These antioxidants delay or inhibit cellular damage mainly 
through their free radical scavenging property [2].
The fluoroquinolones can be classified into four generations based 
on antimicrobial activity. First-generation agents, which are used 
less often today, have moderate Gram-negative activity and minimal 
systemic distribution. The second-generation quinolones have 
expanded Gram-negative activity and atypical pathogen coverage, but 
limited Gram-positive activity [3]. These agents are most active against 
aerobic Gram-negative bacilli. Third-generation quinolones retain 
expanded Gram-negative and atypical intracellular activity but have 
improved Gram-positive coverage. Finally, fourth-generation agents 
improve Gram-positive coverage, maintain Gram-negative coverage, 
and gain anaerobic coverage [4].
Various fluoroquinolones are being used in medicine for treatment 
of number of conditions mainly based on its antimicrobial property. 
The data on the antioxidant property of fluroquinolones are scanty. 
Prulifloxacin and balofloxacin are two such fluroquinolones with 
additional antioxidant property along with their traditional antimicrobial 
effects. Prulifloxacin is a synthetic fluroquinolone prescribed to treat 
complicated and uncomplicated urinary tract infections, community-
acquired respiratory tract infections; gastroenteritis including 
infectious diarrhea. Balofloxacin is recently approved quinolone 
antibiotic prescribed for infective ophthalmitis, sinusitis, chronic 
bronchitis, community acquired pneumonia, and skin infections [5,6]. 
No studies have been done so far comparing the antioxidant potentials 
of prulifloxacin and balofloxacin. Hence, in our study, we have attempted 
to compare the free radical scavenging activity of prulifloxacin and 
balofloxacin using in vitro NO radical. The preference of selecting one 
over the other depends on the indication and risk-benefit ratio.
METHODS
Samples preparation
About 10 mg/ml stock solutions of prulifloxacin and balofloxacin were 
prepared with ethanol (60 µM).
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Principle
NO assay was based on the principle that sodium nitroprusside in 
aqueous solution at physiological pH spontaneously produces NO 
which acts with oxygen to produce nitrite ions, which can be found by 
the use of griess ilosvay reaction (Fig. 1) [7].
Drug source
• Balofloxacin was procured from LUPIN Pharmaceuticals Inc.
• Prulifloxacin was procured from CIPLA Limited.
Reference antioxidant: Vitamin C.
Procedure
The drug was dissolved in distilled water for this quantification. Sodium 
nitroprusside (5 mm) in standard phosphate buffer saline (0.025 M, 
and pH 7.4) was incubated with 100 mg/ml of sample, and tubes were 
incubated at 29°C for 3 hrs. A control experiment without the test 
compounds but with an equivalent amount of buffer was conducted in 
an identical manner. After 3 hrs incubated samples were diluted with 
1 ml of Griess reagent. The absorbance of the color developed during 
diazotization of nitrite with sulfanilamide and its subsequent coupling 
with naphthyl ethylenediamine hydrochloride was observed at 550 
nm on spectrophotometer. The same procedure was conducted with 









The percentage inhibition of NO noted with balofloxacin at 10, 20, 30, 
and 40 mg are 34.49, 49.09, 60.42, and 73.14 and percentage inhibition 
of NO noted with prulifloxacin at 10, 20, 30,  and 40 mg are 40.94, 53.09, 
66.25, and 88.06, respectively (Tables 1 and 2).
DISCUSSION
The free radical oxidative stress has been implicated in the pathology 
of a wide variety of clinical disorders. Numerous physiological and 
biochemical processes in the human body may produce oxygen-centered 
free radicals and other ROS as by-products. Overproduction of such 
free radicals can cause oxidative damage to biomolecules, eventually 
leading to many chronic diseases such as cancer, diabetes, and ageing. 
Antioxidants may offer resistance against the oxidative stress by 
scavenging free radicals, inhibiting lipid peroxidation and by many 
other mechanisms and thus prevent disease [9].
Fluroquinolones are large groups of antibiotics affecting inflammation, 
immunomodulation, cell proliferation, and angiogenesis. These 
antibiotics have been shown to exhibit antioxidant potential; however, 
the exact mechanisms of how the drugs work are unclear. It has been 
suggested that the antioxidant capacity of fluroquinolones is based 
on the inhibition of reactions leading to ROS production and/or on 
direct radical scavenging activity. We have undertaken systematic 
examinations of the reaction of FQs with ROS. Recently, we found that 
FQs are effective scavengers of NO [10]. 
NO is an important chemical mediator generated by endothelial cells, 
macrophages, neurons, and involved in the regulation of various 
physiological processes. Excess concentration of NO is implicated in 
the cytotoxic effects observed in various disorders such as AIDS, cancer, 
Alzheimer’s, and arthritis. The oxygen reacts with the excess NO to generate 
nitrite and peroxynitrite anions, which act as free radicals. Baghiani et al. 
reported that the antioxidant effect of prulifloxacin was greater than any 
other fluroquinolones in an in vitro study. A recent in vitro study has 
reported that clinical concentrations of balofloxacin exert antioxidant 
properties [11]. Talla and Veerareddy have concluded that fluroquinolones 
induce more ROS and produce substantial depletion in both superoxide 
dismutase and glutathione levels particularly with ciprofloxacin that leads 
to cell damage, which is quite contrasting to our result [12].
Goswami et al. concluded that the presence of antioxidants rescues 
bacteria against the antibacterial action of fluoroquinolones. These 
observations are of significance, as fluoroquinolones are important 
antibiotics with immense therapeutic value, and further investigations 
surrounding the intake of antioxidants on the effects of fluoroquinolones 
for the treatment of infections [13].
The percentage inhibition of NO at the low dose (10 mg) of balofloxacin 
and prulifloxacin appears to be almost similar from the Graphs 1 and 2. 
But at subsequent doses, the gap between balofloxacin and prulifloxacin 
widens up, which indicates a significant dose-dependent antioxidant 
potential of prulifloxacin over balofloxacin.
Fig. 1: Principle of nitric oxide assay
Table 1: % Inhibition of NO by prulifloxacin






Table 2: % Inhibition of NO by balofloxacin






Graph 1: % Inhibition of nitric oxide by prulifloxacin and 
balofloxacin
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CONCLUSION
In this study, prulifloxacin, a fluroquinolone showed significant and dose-
dependent free radical scavenging activity by NO radical scavenging 
assay. Free radical scavenging activity of balofloxacin was less significant 
than prulifloxacin but was consistent and non-concentration dependent.
Our in vitro study proves that prulifloxacin has better antioxidant 
activity than balofloxacin. Therefore, prulifloxacin which is an 
antimicrobial drug may be effective also as an antioxidant in a wide 
variety of disease conditions caused by oxidative stress.
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